Dr. Tobi Nagel is Founder and President of Phages for Global Health, a non-profit facilitating the application of antibacterial phages to combat antibiotic resistance in developing countries. Tobi spent 15 years in the pharmaceutical industry co-developing drugs that have been tested in >80 clinical trials. She was a Moonshot Fellow of the Kravis Lab for Social Impact, a Fulbright Specialist roster member, an Advisor to Phages for Human Applications Group Europe, a Scientific Consultant for Global Strategies for HIV Prevention and CRDF Global, and a founding Editorial Board member of the scientific journal PHAGE. She is currently an Advisory Board member for both the Phagebiotics Research Foundation and PhagePro, a company developing cholera phages. Tobi did a Postdoctoral Fellowship at the American Hospital in Turkey and completed a PhD in Medical Engineering at the Harvard-MIT Division of Health Sciences and Technology and a BS in Chemical Engineering at Stanford University.